CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Federal de São Carlos (UFSCAR). Centro de Ciências Biológicas e da Saúde (CCBS) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Nurse and Master's in Nursing from the Federal University of São Carlos. Doctor of Science, concentration field in Physiological Sciences from the Department of Physiological Sciences at UFSCar. Post-Doctorate in Gerontology from the Department of Gerontology at UFSCar. Currently a Doctoral Candidate in Health Sciences at the Nursing Department - UFSCar and in Experimental Pharmacology and Toxicology in the Recerca, Desenvolupament i Control de Medicaments program at the Faculty of Pharmacy and Food Sciences - University of Barcelona/Spain. Researcher contracted by the European Commission - Marie Sklodowska-Curie - Postdoctoral Fellowships - 2025/2026. Collaborate researcher at LABEN - Laboratory of Biology of Aging and CIBERNED - Biomedical Research Networking Center in Neurodegenerative Diseases at the University of Barcelona - Spain. Experience in the field of dementia and blood-based biomarkers of Alzheimer's disease. Works primarily on the following topics: dementia, Alzheimer's disease, elderly, blood-based biomarkers of Alzheimer's disease, cerebrospinal fluid biomarkers of Alzheimer's disease, RT-qPCR, microRNAs, ADAM10 in AD, ADAM10 in other non-AD dementias, cognitive frailty. Period of absence from scientific activities: September 2021 - March 2023 (healthcare treatment). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Dementia is characterized by progressive and global loss of cognitive function to the point of interfering in social and occupational activities of the individual, with dementia of Alzheimer's disease (AD) as a major example. Dementia affects about 5% of the population over 65 and the number becomes more significant after 75 years. Studies suggest that ADAM10 platelet levels in patients w…
Alzheimer's disease (AD) stands out as the leading cause of dementia in the elderly. Molecular biomarkers of direct or indirect relation to the physiopathology of the disease have been identified. Among them, some studies show a decrease of platelet ADAM10 protein in AD patients, as well as the deregulation of microRNAs (miRNAs) related to the gene expression of molecules involved in the …
Although the brain had been once considered an insulin-insensitive organ, several in vivo and in vitro studies have shown that insulin regulates neuronal survival, circuit function and plasticity, and it also acts as a brain growth factor. Moreover, the hippocampus, a key brain region in memory and learning processes, exhibits high levels of insulin receptors and has been identified as an…
The amyloid precursor protein (APP) has been the focus of intense research in recent years because of its association with the Alzheimer´s disease (AD) pathogenesis. In non-amyloidogenic pathway, APP is cleaved by A Disintegrin And Metallopeptidase 10 (ADAM10), an ±-secretase, between lysine16 and leucine17 in the middle of ß-amyloid (Aß) region, thus releasing sAPP± - an structure with n…
| 3 / 3 | Completed scholarships in Brazil |
| 2 / 2 | Completed scholarships abroad |
| 5 / 5 | All Scholarships |
| Associated processes | |